U.S. FDA Authorizes Use of AstraZeneca COVID-19 Antibody Cocktail

The U.S. Food and Drug Administration on Wednesday authorized the use of AstraZeneca’s antibody cocktail to prevent COVID-19 infections in individuals with weak immune systems or a history of severe side effects from coronavirus vaccines. Read More